Jin-Long Chen - Chief Scientific Officer, Ngm Biopharmaceuticals Inc

As of October 13, 2021


Jin-Long Chen Net Worth

  • Net worth is estimated to be at least $35.26M
  • Owns at least 899,449 units of Ngm Biopharmaceuticals Inc stock
  • Sold an estimated value of $10.6M in the last 2 years at Ngm Biopharmaceuticals Inc

Jin-Long Chen Compensation at Ngm Biopharmaceuticals Inc in 2020

  • Earned a $515,000 salary and a $175 bonus
  • Received a total compensation of $2,368,073

Jin-Long Chen Trading

  • Largest purchase of shares was 122,515 units , worth over $110.41K on January 9, 2020
  • Largest sale of shares was 50,765 units , worth over $915.77K on January 9, 2020
  • In total has made about 19 transactions over 2 years
  • Usually trades in September, June, October, February, January, August and November, with the busiest year in 2021 and 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Jin-Long Chen Mailing Address

  • Mailing address is 630 Gateway Blvd. South San Francisco CA 94080 CA

Ngm Biopharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
David J. Woodhouse, Ph.D. 2020 $525,000 $200,000 $3,833,880 $750 $4,559,630
David J. Woodhouse, Ph.D. 2019 $490,000 $125,000 $1,476,400 $750 $2,092,150
Siobhan Nolan Mangini 2020 $199,695 $155,000 $3,458,520 $750 $3,813,965
Jin-Long Chen, Ph.D. 2020 $515,000 $175,000 $1,677,323 $750 $2,368,073
Jin-Long Chen, Ph.D. 2019 $500,000 $125,000 $1,291,850 $750 $1,917,600
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1426332/000162828021007942/ngmbiopharmaceuticalsinc-d.htm

Ngm Biopharmaceuticals Inc Insider Trading

  • The most recent transaction was 30,000 units sold on October 13, 2021 by Jin-Long Chen worth over $608.25K
  • In the last 2 years, insiders at Ngm Biopharmaceuticals Inc sold an estimated value of $10.91M and bought an estimated value of $277.28M
  • The most active traders are Group Column, Director,  David Goeddel V, Director,  and Peter Svennilson
  • Insider trading is most common in June, with the busiest year in 2019

NGM BIOPHARMACEUTICALS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1